Field efficacy of a 10-day treatment of fumagillin against proliferative kidney disease in rainbow trout Oncorhynchus mykiss

Aquaculture

Volumn 171, Issue 1-2, 1999, Pages 27-40

  Le Gouvello, Raphaëla ^a   Pobel, Thierry ^b   Richards, Randolph H ^c   Gould, Christopher ^d  

^a Stermor Kerfahler ^*  (France)

^b SANOFI   (France)

^c UNIVERSITY OF STIRLING   (United Kingdom)

^d Aquaculture Vaccines Limited   (United Kingdom)

Author keywords

Chemotherapy; Fumagillin; Myxosporeans; Oncorhynchus mykiss; PKD; PKX; Rainbow trout; Salmonids

Indexed keywords

AQUACULTURE; DISEASE CONTROL; PARASITIC DISEASE;

ONCORHYNCHUS MYKISS;

EID: 0033557236     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0044-8486(98)00430-X     Document Type: Article

References (34)

1. Alderman D.J., Clifton-Hadley R.S. Malachite green therapy of proliferative kidney disease in rainbow trout: field trials. The Veterinary Record. 122:1988;103-106.
2. Angelidis P., Baudin-Laurencin F., Quentel C., Youinou P. Lower immune response induced by PKD. Journal of Fish Biology. 31:1987;247-250. Supplement A.
3. Bailey L. Effect of fumagillin upon Nosema apis (Zander). Nature. 171:1953;212-213.
4. Clifton-Hadley R.S., Alderman D.J. The effects of malachite green upon proliferative kidney disease. Journal of Fish Diseases. 10:1987;101-107.
5. Clifton-Hadley R.S., Bucke D., Richards R.H. Economic importance of proliferative kidney disease of salmonid fish in England and Wales. The Veterinary Record. 119:1986;305-306.
6. Clifton-Hadley R.S., Bucke D., Richards R.H. A Study of the sequential clinical and pathological changes during proliferative kidney disease in rainbow trout, Salmo gairdneri Richardson. Journal of Fish Diseases. 10:1987;335-352.
7. Commission of the European Communities, 1992. Good clinical practice for the conduct of clinical trials for veterinary medicinal products. III/3767/92, EN Final.
8. de Kinkelin, P., Michel, C., Ghittino, P. (Eds.), 1985. Précis de pathologie des poissons. INRA-OIE, Paris, 347 pp.
9. Di Paolo, J.A., Tarbell, D.S., Moore, G.E., 1958. Studies on the carcinolytic activity of fumagillin and some of its derivatives. Antibiotics Annual, pp. 541-546.
10. Foot J.S., Hedrick R.P. Seasonal occurrence of the infectious stage of proliferative kidney disease (PKD) and resistance of rainbow trout, Salmo gairdneri Richardson, to reinfection. Journal of Fish Biology. 30:1987;477-483.
11. Gerundo N., Alderman D.J., Clifton-Hadley R.S., Feist S.W. Pathological effects of repeated doses of malachite green: a preliminary study. Journal of Fish Diseases. 14:1991;521-532.
12. Hartwig A., Przelecka A. Nucleic acids in intestine of Apis mellifica infected with and treated with fumagillin DCH: cytochemical and autoradiographic studies. Journal of Invertebrate Pathology. 18:1971;331-336.
13. Hedrick R.P., Groff J.M., Foley P., Mc Dowell T. Oral administration of fumagillin DCH protects chinook salmon Oncorhynchus tshawytsha from experimentally induced proliferative kidney disease. Diseases of Aquatic Organisms. 4:1988;165-168.
14. Hedrick, R.P., MacConnell, E., de Kinkelin, P., 1993. Proliferative kidney disease of salmonid fish. In: Faisal, M., Hetrick, F. (Eds.), Annual Review of Fish Diseases, Vol. III. Pergamon, Oxford, pp. 277-290.
15. Higgins M.J., Kent M.L. Field trials with fumagillin-DCH for the control of proliferative kidney disease in coho salmon. Progressive Fish Culturist. 58:1996;268-272.
16. Hustvedt S.O., Storebakken T., Salte R. Does oral administration of oxolinic acid or oxytetracycline affect feed intake of rainbow trout? Aquaculture. 92:1991;109-113.
17. Ingber D., Fujita T., Kishimoto S. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 348:1990;555-557.
18. Jaronski S.T. Cytochemical evidence for RNA synthesis inhibition by fumagillin. The Journal of Antibiotics. 25(6):1972;327-331.
19. Kent M.L., Hedrick R.P. Development of the PKX myxosporean in rainbow trout Salmo gairdneri. Diseases of Aquatic Organisms. 1:1986;169-182.
20. Killough J.K., Magill G.B., Smith R.C. The treatment of amoebiasis with fumagillin. Science. 115:1952;71-72.
21. Lillehaug A., Lunder T., Poppe T.T. Field testing of adjuvanted furunculosis vaccines in Atlantic salmon, Salmo salar L. Journal of Fish Diseases. 15:1992;485-496.
22. MacConnell E., Smith E.C., Hedrick R.P., Speer C.A. Cellular inflammatory response of rainbow trout to the protozoan parasite that causes proliferative kidney disease. Journal of Aquatic Animal Health. 1:1989;108-118.
23. MacHardy G., Frye W.W. Antibiotic in management of amoebiasis. J.A.V.M.A. 154(8):1954;646-651.
24. Marin de Mateo M., Adams A., Richards R.H., Castagnaro M., Hedrick R.P. Monoclonal antibody and lectin probes recognize developmental and sporogenic stages of PKX, the causative agent of proliferative kidney disease in European and North American salmonid fish. Diseases of Aquatic Organisms. 15:1993;23-29.
25. Merriman R.L., Tanzer L.R., Shackelford K.A. Differential cytotoxic action of ovalicin and fumagillin against epithelial cells transformed by ras oncogenes, no. 2442. Proceedings of the American Association for Cancer Research. 31:1990;411.
26. Meyer F.P., Jorgenson T.A. Teratological and other effects of malachite green on development of rainbow trout and rabbits. Transactions of the American Fisheries Society. 112:1988;818-824.
27. Peto R., Pike M.C., Armitrage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: Part II. Analysis and examples. Br. J. Cancer. 35:1977;1-39.
28. Obach Medrano, A., 1993. Influence de différents facteurs de l'environnement sur certains aspects de l'immunité chez le turbot Scophthalmus maximus L., le bar Dicentrarchus labrax L., et la daurade Sparus aurata L. Thèse de doctorat de l'Université de Bretagne occidentale, 131 pp.
29. Saulnier D., de Kinkelin P. Antigenic and biochemical study of PKX, the myxosporean causative agent of proliferative kidney disease of salmonid fish. Diseases of Aquatic Organisms. 27:1996;103-114.
30. Saulnier D., Brémont M., de Kinkelin P. Cloning, sequencing and expression of a cDNA encoding an antigen from the myxosporean parasite causing the proliferative kidney disease of salmonid fish. Molecular and Biochemical Parasitology. 83:1996;153-161.
31. Sovenyi J.F. Effect of fumagillin feeding on the haematopoietic organs and susceptibility of common carp, Cyprinus carpio L., to erythrodermatitis. Journal of Fish Diseases. 15:1992;255-260.
32. Steffens W., Lieder U., Nehring D., Hattop H.W. Möglichkeiten und gefahren der anwendung von malachitgrün in der fischerei. Zeitschrift für Fisherei und Deren Hilfswissenschaft. 10:1961;745-771.
33. Veterinary Medicines Directorate (VMD), 1996. 1995 - Non-statutory surveillance results (final). Medicines Act Veterinary Information Service (MAVIS), April 1996, pp. 19-20.
34. Wishkovsky A., Groff J.M., Lauren D.J., Hedrick R.P. Efficacy of fumagillin against proliferative kidney disease and its toxic side effects in rainbow trout (Oncorhynchus mykiss) fingerlings. Fish Pathology. 25(3):1990;141-147.